Therefore, we speculated that pharmacological activation of S1R might alleviate RV remodeling and attenuate RV dysfunction in a rat PAH model by diminishing oxidative stress associated with the regulation of NRF 2 activity. The gene discussed is TMBIM4; the disease is pulmonary arterial hypertension.